Clinical trial Galahad
A phase 2 efficacy and safety study of Niraparib in men with metastatic castration-resistant prostate cancer and DNA repair anomalies.
Cancers | |
---|---|
Organ | prostate |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Janssen |
EudraCT Identifier | 2016-002057-38 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02854436 |
Inclusion criteria | 2nd line/ RECIST 1.1/ Biopsy |
Last update |